Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAtlantic Lithium Regulatory News (ALL)

If you are a professional, HNW or sophisticated investor and want to learn more about the current funding round for Peloton Minerals, please email kat.perez@focusir.com.

Share Price Information for Atlantic Lithium (ALL)

Share Price is delayed by 15 minutes
Get Live Data
16.20    -0.05 (-0.31%)
Bid:
16.20
Ask:
16.30
Spread: 0.10 (0.617%)
Market Cap: £129.84m
ALL Live PriceLast checked at - London Stock Exchange

Intraday Atlantic Lithium Share Chart

Board Appointment

28 Nov 2013 07:00

RNS Number : 1229U
Allocate Software PLC
28 November 2013
 



28 November 2013

 

ALLOCATE SOFTWARE PLC

("Allocate" or "the Company")

 

Board Appointment

 

Allocate Software plc (AIM: ALL), the leading provider of workforce and compliance optimisation solutions, has appointed Dr Graham Rich (aged 52) as a Non-Executive Director. He will join the board with effect from 1 December 2013.

 

Dr Rich is an experienced former chief executive of NHS hospitals including a Foundation Trust and a primary care trust (PCT) as well formerly holding a position as Director of Commissioning. He is currently a co-founder of CareTechnica Ltd, a company focusing on the commercialization of medical technology. He has also previously worked on national policy formulation and implementation at the Department of Health. His international experience includes health policy formulation and management consulting in the USA.

 

He has particular interest in patient empowerment, the use of IT in healthcare, improved transparency of outcomes and patient satisfaction to drive performance improvement. His specialities include quality improvement, leadership development, value based healthcare and patient safety.

 

Commenting on the appointment, Terry Osborne, Chairman of Allocate said: "I am delighted to welcome Graham to the Board of Directors of Allocate. Graham is a very talented individual with many years experience in the front line of healthcare as a clinician, a chief executive as well as a policy maker and advisor.

 

"His appointment will further strengthen our Board as Allocate continues to increase its presence and influence in healthcare markets." 

 

Graham Rich commented: "I am delighted to be joining the Board of Allocate Software. The company has a very strong suite of products, and is particularly well placed to help hospitals and other healthcare providers face the challenge of becoming safer and more efficient."

 

Details of Dr Rich's current and previous directorships and partnerships in the past five years are set out below.

 

Current directorships and partnerships

CareTechnica Limited

Talking Health Limited

Quality Practice Limited

No.4 Westbury Park Limited

 

 

Previous directorships and partnerships

Doctor Communication Solutions Limited

 

Dr Rich does not currently hold any ordinary shares in Allocate Software plc.

 

There is no further information in connection with the appointment of Dr Rich to the Board of Directors which is required to be disclosed in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

Enquiries:

 

Allocate Software plc

Ian Bowles - Chief Executive

Chris Gale - Chief Financial Officer

 

Tel: +44 (0) 20 7355 5555

Numis Securities

Nominated adviser - Simon Willis/ Richard Thomas

Corporate Broking - James Black

 

Tel: +44 (0) 20 7260 1000

Gable Communications

Justine James

 

Tel: +44 (0) 20 7193 7463

M: +44 (0) 7525 324431

 

About Allocate Software plc

Allocate Software plc is the leading workforce optimisation software applications provider for world-wide organisations with large, multi-skilled workforces. With a blue chip client base spanning the public and private sector, its key vertical markets include Healthcare and Defence.

 

At the core of the business is Allocate's workforce optimisation software, which organisations use to deploy the right people with the right skills, to the right place at the right time. Headquartered in London, Allocate provides services and support to its increasing international customer base through regional offices in the UK, Sweden, USA, Australia and Malaysia.

 

Allocate is quoted on the London Stock Exchange (AIM: ALL). For further information please visit www.allocatesoftware.com.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOALLFEDLRLDFIV
Date   Source Headline
23rd Nov 20239:39 amRNSUpdated Quarterly Activities and Cash Flow Report
22nd Nov 20237:00 amRNSProject Development Update
16th Nov 20237:00 amRNSInvestor Presentation - Noosa Mining Conference
15th Nov 20237:00 amRNSRejection of Non-Binding Indicative Offers
14th Nov 20237:00 amRNSGrant of Highly Prospective Licences for Lithium
10th Nov 20237:00 amRNSConference Attendance
7th Nov 20237:00 amRNSAdditional Resource Extension Drilling Planned
1st Nov 20237:00 amRNSChange of Registered Office
31st Oct 20237:05 amRNSNotice of AGM
31st Oct 20237:00 amRNSQuarterly Activities and Cash Flow Report
20th Oct 20237:00 amRNSMining Lease Granted for Ewoyaa Lithium Project
19th Oct 202311:35 amRNSStatement re Media Speculation
13th Oct 20237:00 amRNSConference Attendance
10th Oct 20237:00 amRNSApproval to Divert Transmission Lines at Ewoyaa
29th Sep 20239:55 amRNSInvestor Presentation
28th Sep 20237:00 amRNS2023 Annual Financial Report
21st Sep 20237:00 amRNSNotice of Results and Investor Presentation
15th Sep 20237:00 amRNSConference Attendance
8th Sep 20237:05 amRNSInvestor Presentation
8th Sep 20237:00 amRNSUS$32.9m Strategic Investment
6th Sep 20237:00 amRNSResource and Exploration Drilling Results
4th Sep 20238:45 amRNSConference Attendance
30th Aug 20237:00 amRNSIssue of Equity - ESOP Options
22nd Aug 20237:00 amRNSIssue of Equity - Exercise of ESOP Options
17th Aug 20237:00 amRNSPartner Commits to Ewoyaa Development Funding
15th Aug 20237:00 amRNSMOU Signed for By-product Feldspar Study
10th Aug 20239:14 amRNSPCA Dealings
9th Aug 20239:30 amRNSDirector/PDMR Dealings
8th Aug 20237:00 amRNSResource and Exploration Drilling Results
7th Aug 20233:13 pmRNSStatement re Media Speculation
31st Jul 20237:00 amRNSQuarterly Activities and Cash Flow Report
19th Jul 20237:00 amRNSConference Attendance
13th Jul 20237:00 amRNSAppointment of Flotation Scoping Study Partner
30th Jun 20237:00 amRNSInvestor Presentation
29th Jun 20238:21 amRNSEwoyaa Definitive Feasibility Study
29th Jun 20237:17 amRNSEwoyaa Definitive Feasibility Study
23rd Jun 202311:00 amRNSBoard Appointments
20th Jun 20237:00 amRNSInitial Infill Drilling Results
16th Jun 20237:00 amRNSConference Attendance
13th Jun 20237:00 amRNSCorporate Update - Resignation of Director
1st Jun 20237:00 amRNSBoard Changes
26th May 20237:00 amRNSDTC Eligibility for OTCQX Electronic Trading
17th May 20237:00 amRNSConference Attendance
16th May 20237:00 amRNSAppointment of Chief Executive Officer
4th May 20237:00 amRNSConference Attendance
28th Apr 20237:00 amRNSQuarterly Activities and Cash Flow Report
26th Apr 20237:00 amRNSInternational Lithium Association Membership
19th Apr 20237:00 amRNSInfill Drilling and Passive Seismic Survey
6th Apr 20237:00 amRNSIssue of Equity – Exercise of ESOP Options
31st Mar 20237:00 amRNSIssue of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.